Abstract:*These authors contributed equally to this work Purpose: Ovarian cancer is one of the most common malignant tumors in gynecology, whose treatment was seriously limited by the unclear understanding of molecular mechanism in disease development. GSG2, also known as Haspin, is a novel molecule found to be involved in human cancers. Materials and Methods: In this study, immunohistochemical analysis was used to detect GSG2 expression in ovarian cancer tissues and corresponding normal tissues. Statistical analysis was performed to construct relationship between GSG2 and tumor characteristics as well as prognosis. Ovarian cell model with GSG2 knockdown was constructed through lentivirus-mediated transfection of shRNA, which was used in MTT assay, colony formation assay and flow cytometry for investigating the role of GSG2 in ovarian cancer. A human apoptosis antibody array was used to identify potential downstream apoptosis-related proteins of GSG2. Results: The results demonstrated the upregulation of GSG2 in ovarian cancer, whose expression was positively related to tumor grade and AJCC stage, and negatively correlated with patients’ prognosis. Moreover, knockdown of GSG2 inhibited ovarian cancer development through suppressing cell growth and inducing cell apoptosis. Further exploration revealed that a variety of apoptosis-related and PI3K signaling pathway-related proteins may be implicated in the GSG2 induced regulation of ovarian cancer. Conclusion: In summary, it was illustrated that GSG2 was involved in the development of ovarian cancer, which has the potential to become therapeutic target and prognostic indicator in ovarian cancer treatment.

Overexpression of small glutamine-rich TPR-containing protein promotes apoptosis in 7721 cells.

SGT, a Hsp90beta Binding Partner, is Accumulated in the Nucleus During Cell Apoptosis.

Up-regulation of SGTB is Associated with Neuronal Apoptosis after Neuroinflammation Induced by Lipopolysaccharide

Cell Surface Beta 1,4-Galactosyltransferase 1 Promotes Apoptosis by Inhibiting Epidermal Growth Factor Receptor Pathway

Overexpression of A Novel Tumor Metastasis Suppressor Gene Tmsg1/Lass2 Induces Apoptosis Via A Caspase-Dependent Mitochondrial Pathway

Over-expression of Testis-specific Expressed Gene 1 Attenuates the Proliferation and Induces Apoptosis of GC-1spg Cells

CXXC4 activates apoptosis through up-regulating GDF15 in gastric cancer.

Transglutaminase 2 inhibits apoptosis induced by calcium- overload through down-regulation of Bax

Identification And Characterization Of Survival-Related Gene, A Novel Cell Survival Gene Controlling Apoptosis And Tumorigenesis

Human Glutathione S-Transferase P1 Suppresses Mekk1-Mediated Apoptosis by Regulating Mekk1 Kinase Activity in Hek293 Cells

GSDMD Enhances Cisplatin-Induced Apoptosis by Promoting the Phosphorylation of Eif2α and Activating the ER-stress Response.

[Effect of Human Granulysin on Apoptosis, Mitochondrial Transmembrane Potential and Cytochrome C Release of SMMC-7721 Cells].

Shuttling SLC2A4RG is Regulated by 14-3-3θ to Modulate Cell Survival Via Caspase-3 and Caspase-6 in Human Glioma

Apoptin induces pyroptosis of colorectal cancer cells via the GSDME-dependent pathway

ISG20L1 acts as a co-activator of DAPK1 in the activation of the p53-dependent cell death pathway

STAT3-PTTG11 abrogation inhibits proliferation and induces apoptosis in malignant glioma cells.

Transcription factor Sp1 transcriptionally enhances GSDME expression for pyroptosis

GLS1 Filament Formation Facilitates Glutamine Deprivation Induced Cell Death

ARTS, an unusual septin, regulates tumorigenesis by promoting apoptosis

Thapsigargin Induces Apoptosis when Autophagy is Inhibited in HepG2 Cells and Both Processes Are Regulated by ROS-dependent Pathway.

Cmar_a_274807 499..508